{
    "nodes": [
        {
            "label": "Company",
            "name": "삼성바이오로직스",
            "properties": {
                "industry": "Biotechnology"
            }
        },
        {
            "label": "Company",
            "name": "셀트리온",
            "properties": {
                "industry": "Biotechnology"
            }
        },
        {
            "label": "Company",
            "name": "유한양행",
            "properties": {
                "industry": "Pharmaceutical"
            }
        },
        {
            "label": "Company",
            "name": "GC녹십자",
            "properties": {
                "industry": "Pharmaceutical"
            }
        },
        {
            "label": "Company",
            "name": "대웅제약",
            "properties": {
                "industry": "Pharmaceutical"
            }
        },
        {
            "label": "Product",
            "name": "피즈치바",
            "properties": {
                "category": "Biosimilar",
                "type": "Biopharmaceutical"
            }
        },
        {
            "label": "Product",
            "name": "램시마SC",
            "properties": {
                "category": "Biosimilar",
                "type": "Inflammatory disease treatment"
            }
        },
        {
            "label": "Product",
            "name": "렉라자",
            "properties": {
                "category": "New Drug",
                "type": "Lung cancer treatment",
                "therapyArea": "Oncology"
            }
        },
        {
            "label": "Product",
            "name": "알리글로",
            "properties": {
                "category": "New Drug",
                "type": "Pharmaceutical"
            }
        },
        {
            "label": "FinancialReport",
            "name": "삼성바이오로직스 Report",
            "properties": {
                "year": 2023,
                "quarter": "Q1",
                "revenue": 12983000000,
                "operatingProfit": 4867000000
            }
        },
        {
            "label": "FinancialReport",
            "name": "셀트리온 Report",
            "properties": {
                "year": 2023,
                "quarter": "Q1",
                "revenue": 8419000000,
                "operatingProfit": 1494000000
            }
        },
        {
            "label": "FinancialReport",
            "name": "유한양행 Report",
            "properties": {
                "year": 2023,
                "quarter": "Q1",
                "revenue": 4916000000,
                "operatingProfit": 640000000
            }
        },
        {
            "label": "FinancialReport",
            "name": "GC녹십자 Report",
            "properties": {
                "year": 2023,
                "quarter": "Q1",
                "revenue": 3838000000,
                "operatingProfit": 800000000
            }
        },
        {
            "label": "FinancialReport",
            "name": "대웅제약 Report",
            "properties": {
                "year": 2023,
                "quarter": "Q1",
                "revenue": 3516000000,
                "operatingProfit": 383000000
            }
        },
        {
            "label": "Reason",
            "name": "바이오시밀러 수출 비중 증가"
        },
        {
            "label": "Reason",
            "name": "국산 신약 매출 증가"
        }
    ],
    "relations": [
        {
            "start_node": "삼성바이오로직스",
            "relationship": "HAS_PRODUCT",
            "end_node": "피즈치바"
        },
        {
            "start_node": "셀트리온",
            "relationship": "HAS_PRODUCT",
            "end_node": "램시마SC"
        },
        {
            "start_node": "삼성바이오로직스",
            "relationship": "HAS_FINANCIAL_REPORT",
            "end_node": "삼성바이오로직스 Report"
        },
        {
            "start_node": "셀트리온",
            "relationship": "HAS_FINANCIAL_REPORT",
            "end_node": "셀트리온 Report"
        },
        {
            "start_node": "유한양행",
            "relationship": "HAS_FINANCIAL_REPORT",
            "end_node": "유한양행 Report"
        },
        {
            "start_node": "GC녹십자",
            "relationship": "HAS_FINANCIAL_REPORT",
            "end_node": "GC녹십자 Report"
        },
        {
            "start_node": "대웅제약",
            "relationship": "HAS_FINANCIAL_REPORT",
            "end_node": "대웅제약 Report"
        },
        {
            "start_node": "유한양행",
            "relationship": "HAS_PRODUCT",
            "end_node": "렉라자"
        },
        {
            "start_node": "GC녹십자",
            "relationship": "HAS_PRODUCT",
            "end_node": "알리글로"
        },
        {
            "start_node": "삼성바이오로직스",
            "relationship": "APPLIES_STRATEGY",
            "end_node": "바이오시밀러 수출 비중 증가"
        },
        {
            "start_node": "셀트리온",
            "relationship": "APPLIES_STRATEGY",
            "end_node": "바이오시밀러 수출 비중 증가"
        },
        {
            "start_node": "유한양행",
            "relationship": "APPLIES_STRATEGY",
            "end_node": "국산 신약 매출 증가"
        },
        {
            "start_node": "GC녹십자",
            "relationship": "APPLIES_STRATEGY",
            "end_node": "국산 신약 매출 증가"
        },
        {
            "start_node": "대웅제약",
            "relationship": "APPLIES_STRATEGY",
            "end_node": "국산 신약 매출 증가"
        }
    ]
}